Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
An SNX31 variant underlies dominant familial exudative vitreoretinopathy-like pathogenesis
Ningda Xu, Yi Cai, Jiarui Li, Tianchang Tao, Caifei Liu, Yan Shen, Xiaoxin Li, Leiliang Zhang, Mingwei Zhao, Xuan Shi, Jing Li, Lvzhen Huang
Ningda Xu, Yi Cai, Jiarui Li, Tianchang Tao, Caifei Liu, Yan Shen, Xiaoxin Li, Leiliang Zhang, Mingwei Zhao, Xuan Shi, Jing Li, Lvzhen Huang
View: Text | PDF
Research Article Genetics Ophthalmology

An SNX31 variant underlies dominant familial exudative vitreoretinopathy-like pathogenesis

  • Text
  • PDF
Abstract

Familial exudative vitreoretinopathy (FEVR) is a complex hereditary eye disorder characterized by incomplete development of the retinal vasculature, which thereby affects retinal angiogenesis. But the genetic factors contributing to FEVR’s development or pathogenesis remain elusive. In a Chinese family with FEVR with 19 members, by using whole-exome sequencing, we identified a candidate disease-causing DNA variant in sorting nexin 31 (SNX31) (c.963delG; p. Trp321Cys), which results in a frameshift mutation. We studied the biochemical mechanism of this mutation and determined that it is deficient in β1-integrin binding and stability. The SNX31 c.963delG point mutation mouse model (SNX31m/m) was constructed with CRISPR/Cas9 technology. At 2–4 months of age, SNX31m/m mice showed fundus phenotypes similar to FEVR-like changes, including vascular leakage and retinal atrophy. Moreover, we found that VEGF and apoptotic pathways were involved in these ocular phenotypes. Hence, our study extended the FEVR mutation spectrum to include SNX31. These findings expanded our understanding of the molecular pathogenesis of FEVR and may facilitate the development of methods for the diagnosis and prevention of FEVR.

Authors

Ningda Xu, Yi Cai, Jiarui Li, Tianchang Tao, Caifei Liu, Yan Shen, Xiaoxin Li, Leiliang Zhang, Mingwei Zhao, Xuan Shi, Jing Li, Lvzhen Huang

×

Figure 6

VEGF pathway–related molecules may be related to retinal vascular defects in SNX31m/m mice.

Options: View larger image (or click on image) Download as PowerPoint
VEGF pathway–related molecules may be related to retinal vascular defect...
(A) The expression of β-catenin in retinal tissues of mice of different ages. No obvious activation or inhibition trend was found for β-catenin. (B) VEGFA, p-ERK, t-ERK, p-Src, t-Src, p-PLCγ1, p-FAK, actin in retinas of 1-, 2-, and 4-month-old WT and SNX31m/m mice. The blots are not from the same lane, but the rest of the conditions are the same. (C) VEGFA increased at 2 months and decreased at 4 months. (D) p-ERK/t-ERK increased at 2 months. (E) p-Src and t-Src increased at 2 months, and the increase was more obvious at the age of 4 months. (F) p-PLCγ1 increased at the age of 2 months. P-ERK, phosphorylated ERK; p-FAK, phosphorylated FAK; p-PLCγ1, phosphorylated PLCγ1; p-Src, phosphorylated Src; t-ERK, total ERK; t-Src, total Src. Statistical analysis was performed via unpaired parametric t test. Data are shown as mean ± SEM. *P < 0.05. See complete unedited blots in the supplemental material.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts